WithintheCOPDGeneticEpidemiology(COPDGene®)studypopulationofcigarettesmokers,9%werefoundto beunclassifiablebytheGlobalInitiativeforchronicObstructiveLungDisease(GOLD)criteria.Thisstudywasto identifythedifferencesincomputedtomography(CT)findingsbetweenthisnonobstructed(GOLDU)groupand acontrolgroupofsmokerswithnormallungfunction.Thisresearchwasapprovedbytheinstitutionalreviewboardof eachinstitution.CTimagesof400participantsintheCOPDGene®study(200GOLDU,200smokerswithnormal lungfunction)wereretrospectivelyevaluatedinablindedfashion
Introduction
Chronic obstructive pulmonary disease (COPD) is a progressiveanddebilitatinglungdiseaseandanimportant causeofmorbidityandmortality,characterizedbyairflow limitationthatisnotfullyreversibleafteradministration ofbronchodilators,accordingtotheGlobalInitiativefor chronic Obstructive Lung Disease (GOLD) and other guidelines. [1] [2] [3] ThespirometricdefinitionofCOPDtypically requiresaratioofforcedexpiratoryvolumein1second to forced vital capacity (FEV1/FVC) of less than 0.7. However,ithasbeendeterminedthatwithincohortsof cigarette smokers, about 8-14% of individuals present withanormalFEV1/FVCratio,butareducedFEV1. [4] [5] [6] A recent study comparing this group, called GOLDnonobstructed(GOLDU),withspirometricallynormal smokersdemonstratedthatGOLDUstatuswasassociated with increased body mass index (BMI), reduced total lungcapacity(TLC),higherratesofnon-whiteindividuals anddiabetesmellitus(DM),aswellasincreasedbronchial wallthickness;however,substantialheterogeneitywithin thisgroupwasobserved. 7 GOLDUindividualsareusually regardedashavingrestrictivelungdisease,butmanyindividualshavetotallungcapacityvalueswithinthenormal range.Individualswithnonobstructedspirometricabnormalitieshavenotbeenfullycharacterizedbyimaging,and itremainsunclearhowtheseindividualsareradiologically different from smokers with normal FEV1 values. 4, 6, 8, 9 Therefore,thepurposeofourstudywastoidentifythedifferencesinCTfindingsbetweenthisGOLDUgroupof individualsandacontrolgroupofsmokerswithnormal lungfunction.
Methods

Clinical Participants
IndividualsforthisstudywereselectedfromparticipantsintheCOPDGene®Study,whichrecruited10,300 currentandformercigarettesmokers,withandwithout COPD, from 21 institutions. 10 Non-Hispanic whites or African-Americansbetweentheagesof45and80years
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withaminimumof10pack-yearssmokinghistorywere includedinthestudy.Exclusioncriteriaincludedpregnancy, history of significant fibrotic lung disease or diffuse bronchiectasis,previoussurgicalexcisionofatleastone lunglobe(orlungvolumereductionprocedure),active cancerundertreatment,knownlungcancer,metalinthe chest, and recent exacerbation of COPD. Two hundred smokingcontrolparticipantsand200GOLDUparticipants wererandomlyselectedforthisstudy,stratifiedsothatthe numbersofmaleandfemaleparticipantswererepresentative ofthemaincohortforeachgroup.Theinstitutionalreview boardsfromeachclinicalcenterapprovedtheanalysesof theclinicalandimagingdata.Individual,informedwritten consentwasobtainedfromallpatients.
CT Examination, Acquisition and Data Analysis
VolumetricCTscanswereobtainedforallparticipants using a standardized technique on multidetector CT scanners. 10, 11 Thescanswereobtainedduringdeepinspiratorybreath-holdatastandardCTdose,andattheendof a normal expiration (functional residual capacity) at reducedCTdoseinacraniocaudaldirectionofthesupine position. Standardized breathing instructions were provided. The typical CT parameters were as follows: submillimetercollimation(0.6-0.75mm)andsubmillimeter reconstruction(thickness:0.625-0.9mm,interval:0.45-0.625 mm)withbothstandardandhigh-frequencyprotocols,120 kVpand200mAsfortheinspirationscanand50mAsfor theexpirationscan. 10, 11 Nopatientreceivedintravenous contrast medium. Anonymized DICOM CT data were transferredtotheimagingcoreforarchiving,qualityassuranceandquantitativeanalysis.
Lobe-Based Quantitative Visual Assessment of CT Images
Lobe-based visual assessment of CT images was performedbyusingstandardreferenceimages. 12 Two radiologistsperformedvisualassessment:reader1and reader2werechestradiologistswith8yearsand10years ofexperience,respectively.Thereaderswereblindtoany clinical and functional information. Image data sets reconstructed with high spatial frequency algorithms were presented to each reader using AquariusNET (TeraRecon, Inc.). Images were presented in random order to the readers in a blinded fashion regarding disease stage. Expiratory volumetric CT images were evaluatedaftertheinspiratoryvolumetricCTdataand therewasnotimelimitationforvisualassessment.The CTimageswerevisuallyinspectedusingawindowwidth of1500Hounsfieldunits(HU)andalevelof-700HU.For thelobe-basedvisualemphysemaassessment,readers were asked to determine the type of emphysema as normal,centrilobular,panlobular,ormixed.Theextent ofemphysemaineachlobewasalsoassessedusinga 6-pointscalesystem:0%,1-5%,6-25%,26-50%,51-75%,and above75%.Thelingulawasregardedasadifferentlobe, resultingin6lobesforeachcase.Thepresenceofairway changes, including bronchial wall thickening and bronchi ectasis,wasalsodeterminedineachlobe.The presenceofcentrilobularnodules,paraseptalemphysema, bullae,andmosaicattenuationpatternatinspirationCT wasassessedandthepresenceofexpiratoryairtrapping was also assessed by comparison of inspiration and expiration CT images. Bronchial wall thickening was visuallydefinedbyaratiooftheinnertoouterlumenof lessthan0.8. 12 Bronchiectasiswasconsideredpresent when the diameter of the inner bronchial lumen was greater than the diameter of the accompanying pulmonaryartery,orwhenabronchuswasvisiblewithin 1cmofthepleuralsurface.Centrilobularnoduleswere defined if more than 50% of a segment was affected. Mosaicattenuationpatternwasdefinedwhenmorethan 25%ofthelobeshowedpatchworkofregionsofdiffering attenuationoninspiratoryCT,excludingareasofemphysema. 13 Expiratoryairtrappingwasdefinedonasideby sidecomparisonofinspiratoryandexpiratoryCTasthe presence of parenchymal area with less than normal increaseinattenuationandlackofvolumereduction, whichinvolvesmorethan25%ofthelobe,excludingareas ofemphysema. 13 Toevaluatepulmonaryparenchymal andchestwallfeatureswhichmightcontributetorestrictive lungabnormality,thefollowingfeatureswereevaluated: presenceofatelectasis(linear,segmental,lobar),fibrotic ornonfibroticinterstitiallungdisease(ILD),including groundglassopacity(GGO),reticularopacity,honeycomb cyst, presence of pleural thickening (diffuse, focal), diaphragmchange(eventration,hernia),andvertebral body change (kyphosis, scoliosis). Diaphragmatic eventrationwasdefinedasafocalabnormalcontourof the diaphragmatic dome. Maximal transverse and antero posteriorinternalthoracicdiameters(mm)were measured.Thenumberofwedgedvertebralbodieswas counted. Presternal subcutaneous fat thickness (mm) was measured at the level of pulmonary trunk; if fat extended outside the field of view, the measurements weremadetotheedgeoffieldofview.Diffusepleural thickening was defined as involving more than 180 degreesofchestwallandmorethan5cmincraniocaudal direction.Focalpleuralthickeningwasdefinedasinvolving lessthan180degreesofchestwallandlessthan5cmin craniocaudaldirection.
Quantitative CT Measurements
WholelungvolumetricCTimagesforquantitative analysiswerereconstructedusingastandardalgorithm. Using commercial software (Pulmonary Workstation, VIDADiagnostics,Inc.),quantitativeCT(QCT)measurements for the emphysema index (EI, %), wall area percentage(WA%),totallungcapacity(TLC CT ,L),and gas trapping (%) were obtained. 10, [14] [15] [16] [17] [18] The software automaticallycalculatedtheEI(%),whichisdefinedas thepercentageoflungvoxelsatorbelow-950HUon inspiratory CT. Quantitative assessment of airway dimensionswasperformedinthesegmental,subsegmental, and subsubsegmental generations of the following bronchial pathways: RB1 (apical segment of RUL), RB4 (lateralsegmentofRML),RB10(posterobasalsegmentof RLL),LB1(apicoposteriorsegmentofLUL),LB4(superior segmentoflingula),andLB10(posterobasalsegmentofLLL). Ineachsegmentalpathway,airwaydimensions,including WA,luminalarea(LA),andWA%weremeasured.Thewall areapercentagewasdefinedasWA%=WA/(WA+LA)x 100. 19 Themeanvalueofthemeasureddimensionsofthe segmental,subsegmentalandsubsubsegmentalgenerations of bronchi was used for statistical analysis. TLC CT was calculatedasthevolumeofvoxelsofthelungandthegas trapping(%),whichisdefinedasthepercentageoflung voxels at or below -856 HU on expiratory CT, was also calculatedautomatically.
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Pulmonary Function Testing
Spirometry was conducted as recommended by the American Thoracic Society (ATS) by highly trained pulmonaryfunctiontechniciansandallspirometrydata wascollectedusingthenddEasyOneSpirometer(Zurich, Switzerland). 10, 20 Each instrument was calibrated daily, andusualassuranceprogramforequipmentchecksand maintenancewasstrictlyfollowed.FEV1,FVC,andratioof FEV1/FVC were evaluated, and were expressed as a percentageofpredictedvalue.Pulmonaryfunctiontests (PFTs)wereperformedonaveragewithin2days(mean, 1.71±5.9)ofobtainingvolumetricCTscans(median0 day). 
Comparison Between GOLDU and Control Group Regarding Parenchymal Abnormalities
The results of comparison between the GOLDU groupandthecontrolgroupforCTparametersrelatedto lungparenchymalabnormalitiesareshowninTable2. Comparedtothecontrolgroup,GOLDUindividualshad significantlygreaterprevalenceofparaseptalemphysema (Figure1),linearatelectasis,andnon-fibroticILDand hadagreaternumberoflobesinvolvedbybronchialwall thickening,bronchiectasis,centrilobularnodules( Figure  2) ,mosaicattenuation,atelectasis,GGO,andreticular opacities(allP<0.05).However,theprevalenceofcentrilobularemphysema,bullae,fibroticILD,honeycombing cystsandextentofemphysemaandexpiratoryairtrapping wasnotsignificantlydifferent.
Comparison Between GOLDU and Control Group Regarding Chest Wall Abnormalities
Regardingthemeasurementofthesubcutaneousfat thickness,inonecasewithinthecontrolgroupand3 casesinGOLDU,measurementswererestrictedbythe edgeoffieldofview.Theresultsofcomparisonbetween GOLDU and the control group regarding chest wall abnormalities are shown in 
Comparison Between GOLDU and Control Group Regarding QCT Measurements
The results of comparisons between GOLDU and thecontrolgroupforQCTparametersareshowninT able3.Comparedtothecontrolgroup,GOLDUparticipants hadsignificantlylowerTLC CT (L)andhigherWA%(allP < 0.0001), but none of the individuals in either group showedTLC CT lessthan80%predicted.Therewereno differencesinEI(%)andgastrapping(%)betweenthe GOLDUandcontrolgroups.
Significant Imaging Features Associated With GOLDU
Afteradjustingforage,race,gender,packyears,and BMI,multiplelogisticregressionanalysisshowedthat significantfeaturesassociatedwithGOLDUwerethe presenceofparaseptalemphysema,linearatelectasis, diaphragmatic eventration, greater number of lobes involved in bronchial wall thickening, bronchiectasis, centrilobularnodules,mosaicattenuation,atelectasis, narrower transverse internal thoracic diameter, and thickersubcutaneousfat(allP<0.05,Table4).Presence ofnon-fibroticILD,kyphosis,extentofGGOandreticular opacities,werenotindependentlyassociatedwiththe GOLDUgroup.Multivariateanalysissuggestedthatthe numberoflobesinvolvedinbronchialwallthickening, centrilobularnodules,linearatelectasis,anddiaphragmaticeventrationallwereassociatedwithreductionof TLC CT (allP<0.05).However,paraseptalemphysema, bronchiectasis, and mosaic attenuation did not show significant associations. One hundred and fifty-eight participants(79%)amongtheGOLDUgrouphadone radiologicfindingthatcouldcontributetopulmonary restrictionsuchasfibroticornon-fibroticILD,GGOs, reticularabnormalities,atelectasis,diffuseorfocalpleural thickening,oreventrationofdiaphragmcomparedwith 103participants(52%)inthecontrolgroup.
Inter-rateragreementsforvisualassessmentinGOLDU and smokers with normal lung function are shown in Table5.
Discussion
In this study, we demonstrated that in the GOLDU group,radiologicfeaturesincludingparenchymallung disease,aswellaschestwallabnormalities,werepresent and could be discriminated from those of the control group of smokers with normal lung function. These findings could be helpful in explaining the unique physio logicfeaturesinGOLDU. ReducedFEV1orFVCinthesettingofapreserved FEV1/FVC ratio is usually regarded as a restrictive pattern on spirometry. In keeping with this, GOLDU participants in our study showed significantly lower TLC CT whencomparedwiththecontrolgroupparticipants. Despite having lower TLC values than control participants,noneoftheGOLDUparticipantshadTLC valuesbelow80%predicted.Ingeneral,reducedTLC CT may be due either to intrinsic lung disease causing increasedlungstiffness,orabnormalitiesofthechest wall,pleura,diaphragm,abdomen,orthoracicbonycage whichaffectventilation.Thisstudydemonstratedthat theGOLDUparticipantsshownotonlyhigherprevalence ofparenchymalabnormalities(paraseptalemphysema, atelectasis,non-fibroticILD,bronchialwallthickening, bronchiectasis,centrilobularnodules,mosaicattenuation, GGO,andreticularopacities),butalsoahigherprevalence of non-pulmonary findings, including diaphragmatic eventration,kyphosis,narrowertransverseinternalthoracic diameterandthickersubcutaneousfat.Furthermore,all of these findings, except GGO, reticular opacities of non-fibroticILD,andkyphosis,remainedassignificant and independent predictors after adjusting for age, race, gender, pack years, and BMI. These covariates werechosenbecausetheyareknowntoaffectpulmonary function. 7 Inpreviousstudies,decreasedFEV1andFVCwith resultantpreservationoftheFEV1/FVCratiohasbeen relatedtoobesitywithincreasedBMI. [21] [22] [23] [24] Inourstudy, thesignificantlyincreasedsubcutaneousfatthicknessin theGOLDUgrouprelativetothatofthecontrolgroup may suggest the importance of obesity as a cause of pulmonaryrestriction.However,highBMIalonedoes notaccountforthereductionofFEV1andFVCinthe GOLDUgroup. 22, 23 Several studies have shown that WA% is related to BMIandWA%variessignificantlybyraceandsex. 25, 26 Inourstudy,evenafteradjustmentforage,sex,andBMI, theGOLDUgrouphadahighernumberoflobesinvolved inbronchialwallthickeningonvisualassessmentand increasedWA%onQCTthanthecontrolgroup.Thismay reflectahigherprevalenceofbronchialinflammationor remodelingintheGOLDUgroup.Thefindingofparaseptalemphysemaasasignificantindependent,associated factorwithGOLDUstatusisinteresting.Wespeculate thatparaseptalemphysemamayactasaspace-occupying lesion in the lung parenchyma, maybe with resultant Physiologically, decreased FEV1 with preservation of FEV1/FVC in GOLDU may be caused by volume derecruitment in alveoli during forced expiration. However, there were no significant differences in gas trappingindex(%)betweenbothgroups,althoughwedid notcomparethegastrappingindex(%)lobe-by-lobein 6regionsofthelung.
Our study has some limitations. First, inter-rater agreementsforvisualassessmentinGOLDUandsmokers withoutCOPDwerevariableandrelativelylow(kappa coefficientrange:0.23-0.69),especiallyinfactorsfound to be different between the 2 groups, identified in adjustedanalysis.However,whenweconsiderthenature oflesionssuchasbronchiectasis,bronchialwallthickening, centrilobular nodules, and mosaic attenuation, these lesionswererelativelysubtlelesionscomparedtothose infaradvancedCOPDandwereliabletobesubjectivein radiologists'readings.Despitetherelativelylowinter-rater agreements,thevalueswereverysimilarinbothgroups, suggesting that the suggested significant imaging featuresassociatedwithGOLDUmightreflectthetrue differencesbydiseasestateratherthanbiasofradiologist's adjudication.Second,althoughstandardizedbreathing instructionswereemployed,itispossiblethatparticipantswereunableorunwillingtoperformanadequate inspiration, which may have contributed to decreased TLCintheGOLDUparticipants.Third,inabilitytomeasure subcutaneousfatthicknessinallcases(becauseoffield ofviewrestriction)isafurtherlimitation.
Inourstudy,wedemonstratethattherewerevariables influencingdiseaseprocessesidentifiableonCT,which mayalsoaffecttheresultsinFEV1andFVC.Underthe current COPD criteria staging system, based on the resultsofspirometry,theheterogeneityofGOLDUmay notbeappreciatedwellinthediagnosisandtreatment of COPD patients. Even though our results showed various meaningful CT parameters in the GOLDU participants,anewGOLDstagingsystemwillbeneeded for allowing the identification of GOLDU individuals havingmorethanoneconcurrentdiseaseprocess. 27 
Conclusion
In cigarette smokers, chest wall abnormalities and parenchymallungdisease,whichcontributetorestrictive physiologic impairment, are associated with GOLDnonobstructedstatus.
